Biohaven Pharma says treatment for acute migraine succeeds in study

Biohaven Pharmaceutical Holding Company Ltd said on Tuesday two doses of its experimental treatment for acute migraine were effective in reducing headaches in a large study, sending its shares up 8% before the bell.